Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
felzartamab (MOR202)
i
Other names:
MOR202, MOR03087, MOR-03087, MOR-202, TJ202
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
HIBio, I-Mab, MorphoSys
Drug class:
CD38 inhibitor
Related drugs:
‹
daratumumab (26)
isatuximab-irfc (12)
daratumumab/hyaluronidase (4)
BHV-1100 (1)
ISB 1342 (1)
K-NK004 (1)
SAR442085 (1)
SAR442257 (1)
TAK-079 (1)
daratumumab (26)
isatuximab-irfc (12)
daratumumab/hyaluronidase (4)
BHV-1100 (1)
ISB 1342 (1)
K-NK004 (1)
SAR442085 (1)
SAR442257 (1)
TAK-079 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
CD47 overexpression + CD38 underexpression
Multiple Myeloma
CD47 overexpression + CD38 underexpression
Multiple Myeloma
ABBV-IMAB-TJC4 + MOR202
Sensitive: D – Preclinical
ABBV-IMAB-TJC4 + MOR202
Sensitive
:
D
ABBV-IMAB-TJC4 + MOR202
Sensitive: D – Preclinical
ABBV-IMAB-TJC4 + MOR202
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login